However, our immunohistochemical staining of OCT2 protein in metastases of different organs is rather homogeneous irrespective of prior treatment suggesting limited evidence of intra-tumor heterogeneity at least for OCT2. The gene discussed is SLC22A2; the disease is neoplasm.